Publications for Mitchell S. Cairo mitchell_cairo@nymc.edu

El-Mallawany, N. K., Day, N., Ayello, J., Van De Ven, C., Conlon, K., Fermin, D., . . . Cairo, M. S. (2015). Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. European Journal of Cancer, 51(1), 92-100. doi:10.1016/j.ejca.2014.10.017

Geyer, M. B., Radhakrishnan, K., Giller, R., Umegaki, N., Harel, S., Kiuru, M., . . . Cairo, M. S. (2015). Reduced toxicity conditioning and allogeneic hematopoietic progenitor cell transplantation for recessive dystrophic epidermolysis bullosa. The Journal of Pediatrics, 167(3), 765-769.e.1. doi:10.1016/j.jpeds.2015.05.051

Huang, X., Park, H., Greene, J., Moy, F., Hamby, C. V., Cairo, M. S., . . . Zhou, X. (2015). IGF1R- and ROR1-specific CAR T cells as a potential therapy for high risk sarcomas. PLoS One, 10(7), [Article: e0133152]. doi:10.1371/journal.pone.0133152

Inamoto, Y., Flowers, M. E., Wang, T., Urbano-Ispizua, A., Hemmer, M. T., Cutler, C. S., . . . Cairo, M. S. (2015). Tacrolimus versus cyclosporine after hematopoietic cell transplantation for acquired aplastic anemia. Biology of Blood and Marrow Transplantation, 21(10), 1776-1782. doi:10.1016/j.bbmt.2015.05.023

Liao, Y., Ivanova, L., Zhu, H., Yahr, A., Ayello, J., Van De Ven, C., . . . Cairo, M. S. (2015). Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa. Stem Cells, 33(6), 1807-1817. doi:10.1002/stem.1966

Minard-Colin, V., Brugieres, L., Reiter, A., Cairo, M. S., Gross, T. G., Woessmann, W., . . . Burkhardt, B. (2015). Non-Hodgkin lymphoma in children and adolescents: Progress through effective collaboration, current knowledge, and challenges ahead. Journal of Clinical Oncology, 33(27), 2963-2974. doi:10.1200/JCO.2014.59.5827

Radhakrishnan, K., Lee, A., Harrison, L. A., Morris, E., Shen, V., Gates, L., . . . Cairo, M. S. (2015). A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors. Pediatric Blood & Cancer, 62(2), 274-278. doi:10.1002/pbc.25309

Raetz, E. A., Cairo, M. S., Borowitz, M. J., Lu, X., Devidas, M., Reid, J. M., . . . Carroll, W. L. (2015). Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2. Pediatric Blood & Cancer, 62(7), 1171-1175. doi:10.1002/pbc.25454

Rosolen, A., Perkins, S. L., Pinkerton, C. R., Guillerman, R. P., Sandlund, J. T., Patte, C., . . . Cairo, M. S. (2015). Revised international pediatric non-Hodgkin lymphoma staging system. Journal of Clinical Oncology, 33(18), 2112-2118. doi:10.1200/JCO.2014.59.7203

Sandlund, J. T., Guillerman, R. P., Perkins, S. L., Pinkerton, C. R., Rosolen, A., Patte, C., . . . Cairo, M. S. (2015). International pediatric non-Hodgkin lymphoma response criteria. Journal of Clinical Oncology, 33(18), 2106-2111. doi:10.1200/JCO.2014.59.0745

Satwani, P., Ahn, K. W., Carreras, J., Abdel-Azim, H., Cairo, M. S., Cashen, A., . . . Hamadani, M. (2015). A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplantation, 50(11), 1416-1423. doi:10.1038/bmt.2015.177

Satwani, P., Jin, Z., Martin, P. L., Bhatia, M., Garvin, J. H., George, D., . . . Cairo, M. S. (2015). Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor risk refractory or recurrent hodgkin and non-hodgkin lymphoma. Leukemia, 29(2), 448-455. doi:10.1038/leu.2014.194

Satwani, P., Jin, Z., Martin, P. L., Bhatia, M., Garvin, J. H., George, D., . . . Cairo, M. S. (2015). Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. Leukemia, 29(2), 448-455. doi:10.1038/leu.2014.194

Shiramizu, B., Goldman, S., Smith, L., Agsalda-Garcia, M., Galardy, P., Perkins, S. L., . . . Cairo, M. S. (2015). Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: A Children's Oncology Group Pilot Study Report. British Journal of Haematology, 170(3), 367-371. doi:10.1111/bjh.13443

Talano, J. A., & Cairo, M. S. (2015). Hematopoietic stem cell transplantation for sickle cell disease: State of the science. European Journal of Haematology, 94(5), 391-399. doi:10.1111/ejh.12447

Abikoff, C. M. & Cairo, M. S. (2014). Reduced intensity conditioning and hematopoietic stem cell transplantation in pediatric nonmalignant disease: A new therapeutic paradigm. The Journal of Pediatrics, 164(5), 952-953.e2. doi:10.1016/j.jpeds.2014.01.061

Abikoff, C. M., Shi, Q., Giller, R., Pulsipher, M. A., Szabolcs, P., Hochberg, J., . . . Cairo, M. S. (2014). A pilot study of unrelated cord blood (UCB) transplantation and unmatched human placental derived stem cells (HPDSC) in pediatric malignant and non-malignant disease. Biology of Blood and Marrow Transplantation, 20(2), S137-138. doi:10.1016/j.bbmt.2013.12.211

Bhatia, M., Jin, Z., Baker, C., Geyer, M. B., Radhakrishnan, K., Morris, E., . . . Cairo, M. S. (2014). Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplantation, 49(7), 913-920. doi:10.1038/bmt.2014.84

Bitan, M., He, W., Zhang, M. J., Abdel-Azim, H., Ayas, M. F., Bielorai, B., . . . Cairo, M. S. (2014). Transplantation for children with acute myeloid leukemia: A comparison of outcomes with reduced intensity and myeloablative regimens. Blood, 123(10), 1615-1620. doi:10.1182/blood-2013-10-535716

Chen, N., Radhakrishnan, K., Krajewski, J., Ricci, A., Geyer, M., Harrison, L., Ozkaynak, M. F., . . . Cairo, M. S. (2014). Low day 100 transplant-related mortality and relapse rate following clofarabine in combination with cytarabine, total body irradiation and allogenic stem cell transplantaiton in children, adolescents and young adults with poor-risk acute leukemia. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S79-S80.

Chu, Y., Yahr, A., Ayello, J., Van de Ven, C., & Cairo, M. (2014). Therapeutic effects of romidepsin, a histone deacetylase inhibitor (HDACI), alone and in combination with natural killer cells against pediatric Burkitt lymphoma. Pediatric Blood and Cancer, 61(S2), S138.

Chu, Y., Yahr, A., Ayello, J., Van De Ven, C., Barth, M., Czuczman, M., & Cairo, M. S. (2014). Anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells significantly mediate rituximab sensitive and resistant Burkitt lymphoma (BL) regression and improve survival in human BL xenografted NSG mice. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S257.

Geyer, M. B., Radhakrishnan, K., Van de Ven, C., Suri, M. S., Ayello, J., & Cairo, M. S. (2014). Enhanced survival during experimental Listeria monocytogenes sepsis in neonatal mice prophylactically treated with Th1 and macrophage immunoregulatory cytokines and mediators  The Pediatric Infectious Disease Journal, 33(12), e330-e337. doi:10.1097/INF.0000000000000442

Goldman, S., Smith, L., Galardy, P., Perkins, S. L., Frazer, J. K., Sanger, W., . . . Cairo, M. S. (2014). Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: A Children's Oncology Group report. British Journal of Haematology, 167(3), 394-401.  doi:10.1111/bjh.13040

Hitzler, J. K., He, W., Doyle, J., Cairo, M., Camitta, B. M., Chan, K. W., . . . CIBMTR Pediatric Cancer Working Committee. (2014). Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatric Blood & Cancer, 61(6), 1126-1128. doi:10.1002/pbc.24918